The Effect of a Single dose Dantrolene in Patients with Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Sabouri, Masih; Momeni, Mahmood; Khorvash, Fariborz; Rezvani, Majid; Tabesh, Homayon

The Effect of a Single dose Dantrolene in Patients with Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Document Type : Original Article

Authors

¹ Department of Neurosurgery, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Cerebral vasospasm is a prolonged, occasionally severe, but reversible narrowing of the cerebral arteries that begins 3 to 5 days after the hemorrhage becomes maximal at 14 days. This study is designed to evaluate the effect of dantrolene on the reduction of vasospasm following aneurysmal subarachnoid hemorrhage (SAH). Materials and Methods: This randomized controlled clinical trial was conducted on 32 patients with proven aneurysms in AL-Zahra hospital during 2011-2013. They were randomly divided into two groups. In all patients, daily transcranial Doppler sonography was performed and as soon as the diagnosis of vasospasm onset in the first group, in addition to conventional treatment of vasospasm 2.5 mg/kg Dantrolene infusion within 60 minutes and while the blood pressure and heart rate of patient monitored, and arterial flow velocity changes such as PSV and MFV were measured by transcranial Doppler sonography in 45, 90 and 135 minutes. Data was analyzed by SPSS 22 and Chi-square, Student t, Mann-Whitney and ANOVA tests with repeated observations. Results: There was no significant difference in the site of the aneurysm in the two groups. The mean of PSV index prior to treatment and the 45^th minute was not different but at 90^th and 135^th minutes it was significantly lower in the Dantrolene receiving group (P < 0.05). The mean of MFV index prior to intervention and in the 45^th minute was not different between two groups, but at 90^th and 135^th minutes was significantly lower in the target group Conclusion: Using dantrolene in patients with artery vasospasm significantly reduced artery spasm and increased the patient recovery.

Keywords

References

1.	Hop JW, Rinkel GJ, Algra A, van Gijn J. Case - fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 1997;28:660-4. [PUBMED]
2.	Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146. [PUBMED]
3.	Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-72.
4.	Gonzalez NR, Boscardin WJ, Glenn T, et al. vasospasm probability index: A combination of transcranial Doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg. 2007;107:1101-1112
5.	Barnwell SL, Higasheda RT, Halbach VV, et al. translominal angioplasty of intercerebral vessels for cerebral arterial spasm: Reversal of neurological deficits after delayed treatment.neurosurgery. 1989;25:424-429.
6.	oropello JM.weiner L, Benjamin E. hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. is it efficacious? NO.crit care clin. 1996;12:709-730.
7.	Tani E, Matsumoto T. Continuous elevation of intracellular Ca2⁺ is essential for the development of cerebral vasospasm. Curr Vasc Pharmacol 2004;2:13-21. [PUBMED]
8.	Williams DA, Becker PL, Fay FS. Regional changes in calcium underlying contraction of single smooth muscle cells. Science 1987;235:1644-8.
9.	Frandsen A, Schousboe A. Dantrolene prevents glutamate cytotoxicity and Ca2⁺ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem 1991;56:1075-8.
10.	Muehlschlegel S, Sims JR. Dantrolene: Mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit Care 2009;10:103-15.
11.	Salomone S, Soydan G, Moskowitz MA, Sims JR. Inhibition of cerebral vasoconstriction by dantrolene and nimodipine. Neurocrit Care 2009;10:93-102.
12.	Muehlschlegel S, Rordorf G, Bodock M, Sims JR. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: A case series. Neurocrit Care 2009;10:116-21.
13.	Neurology in clinical practice the neurological disorders fifth edition volume 2 walter G. Bradley, DM, Fncp. Vascular disease of the nervous system. intracranial aneurysm.subarachnoid hemorrhage. 2008;55:1243-1257.
14.	Muehlschlegel S, Rordorf G, Sims J. Effects of a single dose of dantrolene in patient with creberel vasospasm after subarachnoid hemorrhage: A prospective pilot study. Stroke 2011;42:1301-6.
15.	Flewellen EH, Nelson TE, Jones WP, Arens JF, Wagner DL. Dantrolen does response in awake man: Implications for management of malignant hyperthermia. Anesthesiology 1983;59:275-80.
16.	Lietman PS, Haslam RH, Walcher JR. Pharmacology of dantrolene sodium in children. Arch Phys Med Rehabil 1974;55:388-92.

Advanced Biomedical Research